The U.S. Food and Drug Administration is planning a new warning for Johnson & Johnson’s Covid-19 vaccine over a rare but serious side effect, Guillain-Barré syndrome (GBS).
The FDA proposed new health warnings for cigarette packages and ads due to small size and lack of an image in current warnings.
